source
- STAT+: Pharmalittle: We’re reading about pharma lobbying, Bristol’s deal with a Chinese partner, and moreThe 17 pharmaceutical companies anchoring TrumpRx poured more than $130 million into federal lobbying in 2025 — a nearly 23% surgeSTAT · 3mo ago↗ source
- STAT+: Capsida says it still doesn’t know what caused gene therapy deathSome in the gene therapy field lament lost time while Capsida kept silent about the brain receptor it was targeting when things went wrong.STAT · 3mo ago↗ source
- STAT+: In the battle of sepsis algorithms, performance alone doesn’t predict victoryAs new AI models for predicting sepsis hit the market, experts say performance alone will not drive adoption by hospitals.STAT · 3mo ago↗ source